You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

GYNAZOLE-1 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Gynazole-1, and when can generic versions of Gynazole-1 launch?

Gynazole-1 is a drug marketed by Padagis Israel and is included in one NDA.

The generic ingredient in GYNAZOLE-1 is butoconazole nitrate. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the butoconazole nitrate profile page.

Drug patent expirations by year for GYNAZOLE-1
Recent Clinical Trials for GYNAZOLE-1

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Perrigo CompanyN/A
Padagis LLCN/A

See all GYNAZOLE-1 clinical trials

Pharmacology for GYNAZOLE-1
Drug ClassAzole Antifungal

US Patents and Regulatory Information for GYNAZOLE-1

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Padagis Israel GYNAZOLE-1 butoconazole nitrate CREAM;VAGINAL 200923-001 May 18, 2012 RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.